OCRA Team
Meet Our Team
OCRA is fortunate to have a Board composed of distinguished leaders, a team of talented, caring Staff members, and a renowned Scientific Advisory Committee, who between them have decades of experience fighting ovarian and related gynecologic cancers. Passionate, knowledgeable, and innovative, they are dedicated to improving the lives of those touched by the disease through advancing research, creating imaginative, empathic support programs, encouraging industry collaboration, and fighting legislative battles on Capitol Hill.
Learn About Our Team Members
Never doubt that a small group of thoughtful committed citizens can change the world: indeed, it’s the only thing that ever has.
– Margaret Mead
Related Topics
Mission & Impact
OCRA is dedicated to improving treatments by advancing innovative research, supporting with expertise and empathy those affected by gynecologic cancers to ensure the best possible care and outcomes, raising awareness, and advocating for legislation that tangibly improves patients’ lives.
OCRA-Funded Study Provides Clear New Evidence That Opportunistic Salpingectomy Drastically Reduces Risk of Ovarian Cancer
A new study published February 2 in JAMA Network Open provides the clearest evidence to date that opportunistic salpingectomy—the removal of the fallopian tubes during another gynecologic surgery—can dramatically reduce the risk of ovarian cancer. Led by a B.C.-based international collaboration known as the Ovarian Cancer Observatory, the study found that people who underwent opportunistic … Continued
(Webinar) – Ask the Experts: Gynecologic Sarcoma
Watch Now: Ask the Experts Webinar on Gynecologic Sarcoma On January 28, 2026, Ovarian Cancer Research Alliance (OCRA) hosted a live Ask the Experts: Gynecologic Sarcoma webinar with Matthew Hemming, MD, PhD. Moderated by Liza Lundgren, LCSW, OCRA’s Director of Education, this free session featured a live discussion and audience Q&A focused on gynecologic sarcoma research, … Continued